Fermenta Biotech Ltd.

182.55 +7.20 ▲4.1%

29 February 2024, 04:01:00 PM
Volume: 9,931

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fermentabiotech.com
Market Cap 537.26 Cr.
Enterprise Value(EV) 630.75 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -6.75 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.39 Trailing Twelve Months Ending 2023-12
Book Value / Share 100.86 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.81 Calculated using Price: 182.55
Dividend Yield 0.68 Period Ending 2023-03
No. of Shares Subscribed 2.94 Cr. 29,430,987 Shares
FaceValue 5
About Fermenta Biotech Ltd.
Currently, DIL is engaged in the business of research support services through its subsidiary Research Support International Ltd. (RSIL), manufacture and marketing of enzymes and chemicals through its subsidiary Fermenta Biotech Ltd. (FBL), entertainment through its subsidiary White Stripes Entertainment Ltd. (WSEL) and manufacture and marketing of levitation technology and wheel chairs through its Joint Venture company, being set up in the Czech Republic.

Fermenta Biotech Ltd. Delivery

Delivered Qty
Traded Qty

Fermenta Biotech Ltd. Performance

1 Day
+4.11%
1 Week
-5.88%
1 Month
+17.81%
3 Month
+17.77%
6 Month
+25.21%
1 Year
+38.87%
2 Year
-25.18%
5 Year
-32.35%
10 Year
+350.41%

Fermenta Biotech Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.72 2.08 -6 40.79 64.77 21.92 13.05 4.27 -16.26
Return on Capital Employed (%) 3.68 6.18 1.96 33.86 40.16 12.98 12.62 7.5 -5.35
Return on Assets (%) 0.37 0.99 -2.76 15.85 25.73 10.75 6.56 2.04 -7.69

Fermenta Biotech Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 132 130 144 124 251 309 361 372 315 287
Non Curr. Liab. 14 24 48 146 125 72 131 154 97 54
Curr. Liab. 94 108 86 104 156 195 230 228 229 224
Minority Int. 22 26 28 11 0 0 0 -1 -3 -4
Equity & Liab. 262 288 307 385 532 576 722 753 639 561
Non Curr. Assets 171 195 203 202 226 292 391 419 365 323
Curr. Assets 91 93 104 182 296 284 330 335 274 239
Misc. Exp. not W/O 10
Total Assets 262 288 307 385 532 576 722 753 639 561

Fermenta Biotech Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 142 155 164 303 405 293 377 399 350 343
Other Income 0 1 3 11 27 14 8 8 8 8
Total Income 142 156 167 314 431 307 386 407 358 351
Total Expenditure -126 -135 -152 -212 -269 -229 -295 -336 -331 -302
PBIDT 16 21 15 102 162 79 91 70 26 49
Interest -5 -6 -10 -14 -21 -20 -19 -18 -21 -20
Depreciation -9 -8 -10 -12 -12 -15 -20 -26 -28 -24
Taxation -2 -4 -3 -21 -11 16 -9 -12 -2 -10
Exceptional Items -28 -17
PAT 1 3 -8 55 118 60 43 15 -54 -22
Minority Interest 0 -3 -3 -13 0 0 3 0 2 2
Share Associate 0 -1 0 -8 0
Other Related Items
Consolidated Net Profit 0 -1 -11 34 117 60 46 15 -52 -20
Adjusted EPS 0 0 -4 12 43 21 16 5 -18 -7

Fermenta Biotech Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 14 15 4 2 59 90 34 63 43 117
Cash Fr. Inv. -25 -18 -13 7 -101 -97 -44 -42 -26 -56
Cash Fr. Finan. 13 1 10 -12 89 12 -47 -1 -22 -41
Net Change 2 -2 1 -4 47 6 -57 20 -4 20
Cash & Cash Eqvt 6 3 5 -15 32 38 -18 2 -2 18

Fermenta Biotech Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 59.58 59.58 59.58 59.58 59.58 59.58 62.06 62.06 62.06
Public 40.42 40.41 40.42 40.41 40.42 40.42 37.94 37.94 37.94
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Fermenta Biotech Ltd. Announcements

Tue, 27 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of duplicate share certificate
Mon, 26 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015
Tue, 20 Feb 2024
Intimation Of Earnings Presentation For Quarter 3 - Financial Year 2023-24
Earnings presentation for Quarter 3 - Financial year 2023-24

Fermenta Biotech Ltd. Technical Scans

Wed, 28 Feb 2024
Higher Trade Quantity Higher Trade Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low

Fermenta Biotech Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 377,475.37 1,577.95 +0.3%
Cipla Ltd. 119,187.32 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,206.64 6,424.25 -0.1%
Zydus Lifesciences Ltd. 94,418.40 941.90 +1.0%
Divi's Laboratories Ltd. 93,236.55 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. 91,390.97 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. 88,302.11 2,666.80 +2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.38 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.14 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.51 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.75 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 67.42 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.78 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,666.80 +2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.05 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.60 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.86 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.15 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.53 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,666.80 +2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%

Fermenta Biotech Ltd. FAQ's

What is Fermenta Biotech share price?

Can I buy Fermenta Biotech shares now?

What is the Dividend Yield of Fermenta Biotech?

What is the Market Cap of Fermenta Biotech?

What are the key metrics to analyse Fermenta Biotech?

What is the 52 Week High and Low of Fermenta Biotech?

What is the trend of Fermenta Biotech share price?